IFP Advisors
PYXS icon

IFP Advisors’s Pyxis Oncology PYXS Stock Holding History

IFP Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12 Buy
+5
New +$15 ﹤0.01% 5166
2025
Q2 		– Sell
-17
Closed -$17 – 5001
2025
Q1 		$17 Hold
17
– – ﹤0.01% 4189
2024
Q4 		$27 Buy
+17
New +$49 ﹤0.01% 4406

Other funds holding PYXS

T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $159M AUM 18.68% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
First United Bank & Trust
First United Bank & Trust Oakland, Maryland $347M AUM 18.04% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Mainstream Capital Management
Mainstream Capital Management Los Angeles, California $170M AUM 21% 1-Year Est. Return

IFP Advisors's PYXS Position: Q3 2026 in Review

IFP Advisors opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 5 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #5166 among its holdings. This is a return to the name: IFP Advisors previously reported a position in PYXS as recently as Q1 2025.

IFP Advisors first reported a position in PYXS in Q4 2024 and has held it in 3 quarters since. The position peaked at $27 in Q4 2024. 9 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • IFP Advisors held 5 shares of Pyxis Oncology worth $12 as of Q3 2026.
  • Pyxis Oncology was a new IFP Advisors position in Q3 2026.
  • Pyxis Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5166 holding.
  • IFP Advisors first reported a position in Pyxis Oncology in Q4 2024 and has held it in 3 quarters since.
  • IFP Advisors's Pyxis Oncology position peaked at $27 in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.